FDA approves CBD medicine for epilepsy; DEA must now weigh in

The U.S. Food and Drug administration has approved a naturally derived CBD drug, a landmark decision that will trigger the health agency to seek rescheduling for the cannabinoid from the Drug Enforcement Administration (DEA).

The FDA signed off on the use of Epidiolex, a drug from Britain’s GW Pharmaceuticals, to treat two kinds of epilepsy. The decision caps decades of work by the company to gain approval in the U.S. for a medicine derived from the cannabis plant.

Read more on Hemp Industry Daily

For Local Pickup or Inquiries, please Call 484-580-6943 or Email orders@pure4life.co

Located at: 351 E. Conestoga Road, Wayne, PA 19087

CBD In The News

FDA Disclosure:

Statements made in this website have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. Always check with your health professional before starting a new dietary supplement program. The Food and Drug Administration (FDA) considers non-THC based hemp products to be "food based" and therefore legal without a medical marijuana license. CBD Rich Hemp Oil is legal in all 50 states. The Good Earth Global CBD Oil Products Contain zero THC unless specified. Legal Disclaimer: The Good Earth Global or affiliates do not sell, distribute, or manufacture any products that are in violation of the United States Controlled Substances Act (US.CSA). Legal in the USA - CBD is legal in the United States when contained within hemp oil under the 2014 Farm Bill.

Disclaimer:

All products are THC-free. Information provided in this website is intended as a guide only and does not constitute legal advice. We endeavor to keep the information up to date and correct however make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is at your own risk.